Scroll Back to Top

Study number 779857

Healthy Adults, age 18-65 needed

Dates

Apr 30 2026-Jul 10 2026

Group

Cohort 5 OR 8

Location

Daytona Beach, Florida

Age

18-65

Gender

Male OR Female

Smoker

Yes

Compensation

$12,049

Referral

$350

Study Details

This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. 

Daytona Beach, FL is currently recruiting Healthy Adults, ages 18-65. 

Refer a friend & receive $350 per qualified referral

Women Eligibility Criteria

  • Women can be of childbearing potential or non-childbearing potential.

Smoking Criteria

  • Smoking is allowed. 

Body Mass Index

  • Participants must have a BMI of:
    • 18-34

Screening procedures

  • Screening procedures for this study may include:
    • Vitals
    • Physical examination
    • Electrocardiogram (ECG)
    • Collection of blood samples
    • Drug and Alcohol testing  

Additional Details

Call Now to Schedule Your Screening Appointment! 
 

Cohort 5: 
Check-in: Apr 30
Check-out: May 1

Follow up Visits: May 3, 5, 8, 11, 15, 22, 29, Jun 12, 26, Jul 10

Phone Calls: Jun 5, 19, Jul 3
 

Compensation Schedule: 
Day 11 (May 11): $3,794
Day 22 (May 22): $2,355
Day 43 (Jun 12): $1,570
Day 57 (Jun 26): $1,620
Day 71 (Jul 10): $2,710

OR 

 

Cohort 8: 
Check-in: May 6
Check-out: May 7

Follow up Visits: May 9, 11, 14, 17, 21, 28, Jun 4, 18, Jul 2, 16 

Phone Calls: Jun 11, 25, Jul 16
 

Compensation Schedule: 
Day 11 (May 17): $3,794
Day 22 (May 28): $2,355
Day 43 (Jun 18): $1,570
Day 57 (Jul 2): $1,620
Day 71 (Jul 16): $2,710

BMI Calculator

Weight

Height

Feet Inches